background: Increasing age and post-menopausal status are associated with decreasing androgen concentrations in females. Women with premature loss of ovarian function, such as primary ovarian insufficiency (POI) or iatrogenic menopause may be at increased risk for diminished testosterone levels at a relatively young age. Differentiation between a hypoandrogenic or normoandrogenic state in women with premature loss of ovarian function is problematic due to trueness and precision problems using various testosterone assays. The current meta-analysis was conducted to evaluate current literature reporting serum total testosterone concentrations under these conditions, including stratification for various testosterone assays.
background: Increasing age and post-menopausal status are associated with decreasing androgen concentrations in females. Women with premature loss of ovarian function, such as primary ovarian insufficiency (POI) or iatrogenic menopause may be at increased risk for diminished testosterone levels at a relatively young age. Differentiation between a hypoandrogenic or normoandrogenic state in women with premature loss of ovarian function is problematic due to trueness and precision problems using various testosterone assays. The current meta-analysis was conducted to evaluate current literature reporting serum total testosterone concentrations under these conditions, including stratification for various testosterone assays.
methods: A systematic review and meta-analysis of controlled observational studies were performed. The electronic databases of Pubmed, Embase and the Cochrane Library were systematically searched until October 2011 for comparative studies on total testosterone concentrations in women with spontaneous POI or iatrogenic menopause compared with controls. The literature search, data extraction and critical appraisal, using the Newcastle -Ottawa Scale, were performed by two independent investigators. The effect measure was the weighted mean difference (WMD) with 95% confidence interval (95% CI) in a random effects model. results: A total of 206 articles for spontaneous POI and 1358 for iatrogenic menopause were reviewed, of which 9 and 17 papers, respectively, were selected for final analysis. Both groups demonstrated significantly lower total testosterone concentrations compared with controls [WMD (95% CI) 20.38 (20.55 to 20.22) nmol/l, and 20.29 (20.39 to 20.18 ) nmol/l, respectively], but with substantial
Introduction
While spontaneous menopause typically occurs around the age of 51 years (Treloar, 1981) , 1-2% of women experience menopause before the age of 40 years (Coulam et al., 1986) . Spontaneous premature cessation of ovarian function, currently known as primary ovarian insufficiency (POI) or premature ovarian failure (POF), is characterized by amenorrhea for at least 4 months along with repeatedly elevated FSH concentrations in the post-menopausal range and a hypo-estrogenic state (Cooper et al., 2010; de Vos et al., 2010) . Spontaneous POI may be caused by steroidogenic cell autoimmunity (Bakalov et al., 2005) , numerical or structural chromosomal abnormalities, such as monosomy X (Mattei et al., 1982) , or monogenic causes, including the fragile X premutation (Wittenberger et al., 2007) and other single gene mutations (Qin et al., 2007; Rossetti et al., 2009; Janse et al., 2012) . In the great majority of women diagnosed with POI, however, the mechanisms underlying premature exhaustion of the ovarian follicle pool remain unknown. Most probably, POI should be regarded as a complex genetic disease in which multiple genetic variants along with environmental factors may play important roles (Knauff et al., 2009) .
Another group of post-menopausal women, who do not fit the description of physiologic menopause, are women who experienced menopause due to gonadotoxic treatment (such as chemotherapeutic agents and irradiation), or extensive abdominal surgery and oophorectomy. Because the long-term survival in women treated for cancer has greatly improved during recent decades (Altekruse et al., 2010) , the incidence of women with iatrogenic menopause due to either benign or malignant disease has now increased to 3.4-4.5% (Graziottin, 2010) .
Spontaneous POI and iatrogenic menopause are associated with infertility, and increased risk of osteoporosis (Yildiz et al., 1996; Uygur et al., 2005) , cardiovascular disease (van der Schouw et al., 1996; Kalantaridou et al., 2004; Knauff et al., 2008) and diminished emotional well-being (van der Stege et al., 2008) . Most known health risks in women with spontaneous POI and iatrogenic menopause are attributed to the low estrogen concentration in these women.
However, some studies suggest that these women may also be at risk for low testosterone concentrations (Bachmann et al., 2002; Davis, 2002; Rivera-Woll et al., 2004) . Until now, it has been debated whether the post-menopausal ovary remains a significant source of androgen production. There is conflicting evidence indicating that hypoandrogenism in post-menopausal women may derive from a gradual decrease in both ovarian and adrenal production of androgens with increasing age (Davison et al., 2005) , while others suggest that only ovarian androgen production further decreases during the menopausal transition (Rannevik et al., 1995; Couzinet et al., 2001) .
Hypoandrogenemia is described in association with the female androgen insufficiency syndrome (FAIS). The Princeton Consensus Statement proposed the following clinical symptoms for the description of FAIS: (i) diminished sense of well-being or dysphoric mood, (ii) persistent, unexplained fatigue and (iii) sexual function changes (Bachmann et al., 2002) . Besides FAIS, decreased testosterone concentrations have been associated with multiple general health consequences in peri-and post-menopausal women. These include increased risks of dyslipidemia (Khatibi et al., 2007) and coronary heart disease events (Patel et al., 2009; Laughlin et al., 2010) . These associations remain controversial, however, because other studies have found no or even reverse effects on risks of metabolic syndrome (Bell et al., 2006; Janssen et al., 2010) or cardiovascular disease (Kalyani et al., 2009) . In contrast, from existing literature, it becomes clear that the lower total testosterone concentrations are associated with increased fracture risk (Lee et al., 2008) and decreased bone density (Rariy et al., 2011) . Furthermore, associations between low testosterone concentrations and decreased verbal fluency (Drake et al., 2000) , and increased frailty in the elderly (Wu et al., 2010) have been described.
Although some studies (Somboonporn et al., 2005; Traish et al., 2007) and guidelines (North American Menopause Society, 2005) have advocated a beneficial effect of androgen therapy in hypoandrogenic women, the evidence is controversial and the Endocrine Society Clinical Practice Guidelines do not recommend androgen therapy until the physiological role of androgens has become clear and the clinical syndrome of androgen deficiency is better defined (Wierman et al., 2006) .
The diagnoses of FAIS and other health risks possibly associated with hypoandrogenemia are complicated by the lack of reliable testosterone assays and the need for age-adjusted reference values (Rosner and Vesper, 2010; Haring et al., 2011) . Simple radioimmunoassay (RIA) and chemiluminescence immunoassay are performed directly in serum, but show more bias in the lower range encountered in women, due to increased interference and overestimation of steroid concentrations compared with other assays (Boots et al., 1998; Stanczyk et al., 2003) . The addition of extraction and chromatography procedures before the use of RIA removes these interfering proteins and cross-reacting steroids, but extraction is labor intensive and timeconsuming (Rosner and Vesper, 2010) . A third type of testosterone assay is the liquid chromatography-tandem mass spectrometry (LC-MS/MS). This assay has the advantage of chromatographic separation and mass spectrometry analysis, leading to an equal or better precision compared with most other assays, and is much less time-consuming. However, like extraction/chromatography RIAs, standardization is still lacking for LC-MS/MS (Vesper et al., 2008) . Finally, most circulating testosterone is biologically inactive due to binding to serum proteins, primarily sex hormone-binding protein (SHBG) and albumin (Dunn et al., 1981) . Free testosterone (FT) is the unbound component of total testosterone, while bioavailable testosterone is defined as the concentration of testosterone that is free or weakly-bound. While FT may correlate better with the patient's clinical androgenic state, the measurement of FT is even more complicated because FT is only a small proportion of total testosterone (Rosner et al., 2007) . Instead of measuring FT concentrations itself, the free androgen index (FAI; testosterone/SHBG) is often calculated. However, the FAI is also highly dependent on the quality of testosterone and SHBG assay measurements (Vermeulen et al., 1999) .
Multiple studies have investigated serum total testosterone concentrations in women with spontaneous POI or iatrogenic menopause. However, due to the low incidence of ovarian insufficiency and the heterogeneity of iatrogenic menopause, most studies included small sample sizes. Moreover, different total testosterone assays were applied and control groups were not uniform. The current systematic review and meta-analysis were aimed to investigate total testosterone concentrations in women with spontaneous POI and iatrogenic menopause, and to identify whether these women are at risk for hypoandrogenemia, while introducing subgroup analyses for the constitution of control group and testosterone assay that was used.
Methods

Search strategy
The electronic databases of MEDLINE, EMBASE and the Cochrane Library were consulted from inception until October 2011 for the identification of suitable papers. A search strategy was carried out based on synonyms of 'POI', 'iatrogenic menopause' and 'testosterone' in titles and abstracts. Synonyms were identified by selecting relevant items included in the indexed MeSH search terms and by reviewing relevant literature for new relevant synonyms not mentioned by MeSH. Two separate searches were carried out: one for testosterone concentrations in spontaneous POI, and one for testosterone concentrations in iatrogenic menopause.
For the first search, the following terms were included in the MEDLINE search: ('POF'[tiab] In addition, a hand search of reference lists of relevant review articles and those of included studies was conducted to locate any other potentially eligible studies. When necessary, authors were contacted to gain additional information.
Selection criteria
All published studies in which serum total testosterone concentrations were described for women with spontaneous POI or surgical menopause and compared with healthy controls, were considered eligible for this systematic review and meta-analysis. The criteria for spontaneous POI had to be consistent with the definition of POI by the WHO III criteria: amenorrhea for at least 4 months, occurring before the age of 40 years, along with repeated elevated FSH to a menopausal level and decreased estradiol (E 2 ) concentrations (Coulam et al., 1986; Cooper et al., 2010) . Iatrogenic menopause was defined as women who underwent bilateral salpingo-oophorectomy (BSO) or became post-menopausal due to gonadotoxic treatment (such as chemotherapy or irradiation) before natural menopause occurred (Wulf, 2004) . Controls were required to be women without POI or iatrogenic menopause. Both similar-aged, cycling controls as well as naturally post-menopausal controls were considered eligible.
Exclusion criteria were hyperandrogenemia, BSO or gonadotoxic treatment performed after menopause had occurred, the use of hormone therapy, studies focusing on men or animals and studies without a control group. Studies focusing only on chromosomally abnormal POI patients, such as Turner syndrome, or women with galactosaemia, were excluded. Reviews, case-reports, letters to the editor, conference papers and studies published in languages other than English, Dutch or German were also excluded.
The process for study selection was conducted in two phases. First, titles and abstracts were screened to meet the inclusion criteria by two independent investigators (F.J. and S.J.T.) to avoid selection bias (Fig. 1) . Final inclusion occurred after the examination of full text. Any disagreement was resolved by consensus or a third reviewer (B.C.J.M.F.).
Data extraction
From each study included for review, the following information was extracted by two investigators independently (F.J. and S.J.T.) using a standardized data extraction form: author, year of publication, study design, patient population characteristics (criteria, sample size, age, BMI and time since POI/iatrogenic menopause), constitution of controls and a description of the applied total testosterone assay (Tables I and II) . Total testosterone concentrations were also extracted from relevant studies. When data were presented in subgroups within a study, pooled means and pooled mean standard deviations (SD) were calculated, using the following formula:
where n is the sample size, SD the standard deviation and m the mean. Any testosterone concentrations reported as conventional units (ng/ml or ng/dl) were converted into SI units (nmol/l) by multiplication of the data by 3.467 or 0.03467, respectively. Reported SEM were converted to SD with the following formula:
where SD is the standard deviation, SEM the standard error of the mean and n the sample size. Geometric means and 95% confidence Testosterone in ovarian insufficiency intervals (CIs) were converted into arithmetic means and SDs using the equivalence of the logarithm of a geometric mean and the log-normal distribution. When necessary, authors were contacted to gain additional information.
Critical appraisal
Included studies were critically appraised by two independent reviewers (F.J. and S.J.T.) according to the Newcastle-Ottawa Scale for meta-analysis of observational studies (Wells et al., 2000) and following the Cochrane risk of bias assessment (Higgins and Green, 2011) (Table II and Supplementary data, Tables SI and SII) . The following criteria were assessed: representativeness of cases (spontaneous POI or iatrogenic POI), selection of control groups and comparability between these groups. Studies in which control women were matched for important factors associated with testosterone concentration, such as age, BMI and duration of amenorrhea, were considered as higher quality studies. Furthermore, validity of the outcome measurement (testosterone concentration measurement) and non-response rates were assessed. Low methodological quality was not an exclusion criterion. Again, any disagreement among the investigators was dissolved by consensus.
Statistical analysis
Weighted mean differences (WMDs) and associated 95% CIs were calculated for the comparison of testosterone concentrations between spontaneous POI and controls, and between iatrogenic menopause and controls in a random effects model. The degree of heterogeneity between the results of the different studies was examined by inspection of funnel plots, the overlap in the CIs and the Higgins Index (I   2   ) .
Furthermore, subgroup analyses for testosterone assay and for constitution of controls were conducted to examine their contribution to testosterone concentrations. Finally, sensitivity analyses of high-quality studies were performed. The high-quality studies were defined as a high Newcastle-Ottawa score and studies in which confounding factors for testosterone concentration such as age, BMI and time since menopause did not differ between cases and controls. All analyses were performed with RevMan version 5.1 (2011).
Results
Characteristics of included studies
The systematic searches yielded 468 and 2413 studies for spontaneous POI and iatrogenic menopause, respectively (Fig. 1 ). Duplicates were removed using Reference Manager, which resulted in 206 and 1358 available studies for the review process, respectively. On the basis of a priori defined selection criteria, screening title and abstract resulted in the exclusion of 183 studies for spontaneous POI and 1316 studies for iatrogenic menopause. Full text papers were retrieved for both searches (23 and 42, respectively) and reviewed on the basis of the selection criteria. For spontaneous POI, 14 full-text studies were excluded: 1 study (Bernardi et al., 1998) was excluded due to identical results as a previously published study (Hartmann et al., 1997) , 2 studies were excluded because POI diagnosis did not meet the predefined criteria (Aloia et al., 1985; Ludwig and Wolters, 2007) , 3 studies did not include female controls (Duignan et al., 1978; Bachelot et al., 2005; Knauff et al., 2008) , 1 study did not measure serum testosterone concentrations (Mason et al., 2006) , 1 study focused only on women with galactosaemia (Kaufman et al., 1987) , 1 study was a review paper (Arlt, 2003) , 2 studies were conference abstracts (Grech and Panay, 2008; Woodman et al., 2009 ) and 3 studies were excluded because of language other than English, Dutch or German (Stanosz et al., 1995; Berlier et al., 1999; Skalba et al., 2006) .
For iatrogenic menopause, 25 full-text studies were excluded: 1 study (Oriana et al., 1982) was excluded due to identical results as a previously published study (Preda et al., 1979) , 3 studies were excluded because post-menopausal oophorectomy was performed (Lukanova et al., 2004; Antoniucci et al., 2005; Fogle et al., 2007) , in 1 study it was unclear whether the gonadotoxic treatment resulted in a post-menopausal status (Eby et al., 1989) , 12 studies did not include female controls (Horton et al., 1966; Judd et al., 1974; Chakravarti et al., 1977; Dennerstein et al., 1978; Dowsett et al., 1988; Hughes, Jr. et al., 1991; De Leo et al., 1998; Azzena et al., 2002; Nozaki et al., 2004; Mason et al., 2006; Nar et al., 2009; Kalyan et al., 2011) , 2 studies did not measure total T (Forsling et al., 1996; Acar et al., 1998) , in 1 study women used hormone therapy (Schmitt-Robe et al., 1992) , 1 study did not report postoophorectomy testosterone-values (Preda et al., 1979) , 1 study was a conference record (Bucuras et al., 2010 ) and 3 studies were excluded because of language other than English, Dutch or German (Bassalyk et al., 1986; Halerz-Nowakowska, 1995; Kulak et al., 2009) . In addition, a hand search was performed which resulted in the identification of 4 new eligible studies for iatrogenic menopause, while no additional studies were found for spontaneous POI. Finally, 9 studies on spontaneous POI and 21 studies on iatrogenic menopause were included for critical appraisal and meta-analysis.
The characteristics of the included studies for spontaneous POI are reported in Table I . In most studies, POI diagnosis was reported as a post-menopausal FSH concentration .40 IU/l. Two studies did not adhere to this strict cut-off for FSH, due to describing FSH as 'elevated' (Elias et al., 1997) or using a cut-off of only 25.6 IU/l (Doldi et al., 1998) , but these studies still met the selection criteria set by the investigators. All studies incorporated a control group with a regular menstrual cycle pattern, while two studies also included a post-menopausal control group (Hartmann et 
Cross-sectional case control n ¼ 33, age 28.7 + 4.9 years, BMI 22.5 + 3.6 kg/m 2 , duration of amenorrhea 2.5 + 1.3 years n ¼ 33, regular cycle, age 28.3 + 4.9 years, BMI 21.6 + 2.6 kg/m 2 And n ¼ 32, post-menopausal, age 53.1 + 2.6 years, BMI 24.5 + 2.6 kg/m 2 , duration of amenorrhea 2.6 + 1.4 years Direct RIA; intra-assay CV 6.5%; inter-assay CV 11.2%; LLOD 0.14 nmol/l Elias et al. (1997) Cross-sectional case control n ¼ 208, age 37.1 + 7.6 years, BMI 24.4 + 4.1 kg/m 2 n ¼ 45, regular cycle, severe male infertility, FSH ,12 IU/l, age 32.8 + 3.5, BMI 24.7 + 6.6 kg/m 2 Extraction/chromatography RIA; intra-assay CV 3.5-3.8%; inter-assay CV 6-10%; LLQ 0.10 nmol/l Data shown as mean + SD, unless stated otherwise. POI, primary ovarian insufficiency; BMI, body mass index; HT, hormone therapy; RIA, radioimmunoassay; CV, coefficient of variation; LLOD, lower limit of detection NR, not reported. Direct RIA; intra-assay CV 2.1%; inter-assay CV 2.5%; LOD NR Continued was applied in five studies, while four studies incorporated extraction/ chromatography steps before RIA was applied.
Details for the included studies for iatrogenic menopause are described in Table II . In the included studies, iatrogenic menopause was mostly a result of BSO with (n ¼ 7) or without hysterectomy (n ¼ 14). One study in women with cervical cancer included two groups with possible iatrogenic menopause: one treated by BSO, and one by irradiation (Inskip et al., 1994) . Reasons for BSO were benign or prophylactic in five studies, while BSO was performed because of cancer in three studies. However, 13 studies did not describe reasons why BSO was carried out. Controls consisted of women with natural menopause (n ¼ 13), women with hysterectomy only (n ¼ 4) or were cycling women (n ¼ 3). One study included both cycling controls and women with natural menopause (Labrie et al., 2011) . There were 11 studies which applied extraction/chromatography and RIA, two used (isotope dilution-) LC-MS/MS, one used gas chromatography-MS (GC-MS) and the remaining studies used direct RIA (n ¼ 6). One study did not mention the type of testosterone assay that was used (Beksac et al., 1983) .
Methodological quality
The quality assessment for studies selected for the comparison of testosterone concentrations in spontaneous POI versus controls is reported in Table III (summary) and in Supplementary data, Table SI. All but two studies adjusted for the important confounders age and BMI, or duration of menopause and BMI. However, in five out of nine studies selection bias could not be excluded because recruitment procedures for women with spontaneous POI and controls were not described. Of the remaining four studies, two included all consecutive POI patients, while two invited these women with advertisements, internet or through recruitment letters to physicians. In these four studies, controls were selected from different population samples (general population or hospital population) than cases. Completeness of sample (non-response rate) was not reported in any of the studies, thus indicating a high risk for attrition bias. Blinding of laboratory personnel was not described in any study, thereby introducing a possible detection bias. However, performance bias was not suspected due to the fact that identical testosterone assays were employed in all case-control comparisons. The influence of reporting bias could not be assessed. In summary, three studies (Kalantaridou et al., 2006; van der Stege et al., 2008; Janse et al., 2011) scored 7 points or higher on the Newcastle-Ottawa scale, indicating good methodological quality.
For the comparison of testosterone concentrations in iatrogenic menopause versus controls, the quality assessment for included studies are reported in Table III 3. Non-response rate (a) same rate for both groups* (b) non-respondents described and (c) rate different and no designation confirmed by medical records, however, four studies relied on selfreport only and three studies did not mention any procedure for how the diagnosis was confirmed. Cases and controls were matched on or adjusted for age and BMI, or time since menopause and BMI, in six studies. There are indications for selection bias in most studies, because 10 papers only matched on or adjusted for one of these confounders, while in five studies no matching or adjustment was performed at all. Moreover, recruitment procedures of cases or controls were not described in nine and six studies, respectively. There were eight studies which used identical populations for the recruitment of controls. All studies were at risk for attrition bias, because response rate for both cases and controls was not described for any of the studies. Again, blinding of laboratory personnel was not described in any study (introduction of possible detection bias), but performance bias was not suspected because of the use of identical testosterone assays in all case -control comparisons. Assessment of reporting bias was not possible. Summarizing the NewcastleOttawa scale assessment, three studies (Sowers et al., 2001; Laughlin et al., 2000; Korse et al., 2009 ) scored 7 points or higher, and were therefore considered as the best available evidence.
Testosterone concentrations in spontaneous POI
The nine studies included in the meta-analysis reported total testosterone concentrations in 529 women with spontaneous POI and in 319 controls. Women with spontaneous POI demonstrated significantly lower total testosterone concentrations compared with controls (nine studies); WMD (95% CI) 20.38 (20.55 to 20.22) nmol/l. However, substantial between-study heterogeneity was identified (I 2 ¼ 81%) (Fig. 2) Fig. S2 ). In the sensitivity analysis, the difference in total testosterone concentrations between women with spontaneous POI and controls remained robust [three studies, WMD (95% CI): 20.31 (20.46 to 20.15) nmol/l], and resulted in a substantial decrease in heterogeneity (I 2 ¼ 51%) (Fig. 3) .
Testosterone concentrations in iatrogenic menopause
Due to incomplete data and non-responsive authors, the following studies could not be included in the meta-analysis (n ¼ 4): in one study only mean ratios without original data were reported (Inskip et al., 1994) , two studies reported geometric means without 95% CIs and data could therefore not be converted into means and SDs (Studd et al., 1978; Danforth et al., 2010) and one study did not mention SD for cases (Lanb et al., 1964) . The 17 studies included in the meta-analysis reported data on 558 women with iatrogenic menopause and 2425 controls. In women with iatrogenic menopause, total testosterone concentrations were significantly lower than in controls (17 studies , but between-study heterogeneity remained substantial (I 2 ¼ 83%) (Fig. 5 ).
Discussion
The current systematic review of the literature and subsequent meta-analysis was set up to assess for the first time whether serum total testosterone concentrations in women with spontaneous POI or iatrogenic menopause are different from women who experience natural menopause at a regular age. For spontaneous POI, pooled total testosterone concentrations were significantly lower compared with controls: WMD (95% CI) 20.38 (20.55 to 20.22) nmol/l. The difference between pooled total testosterone concentrations in Figure 3 Sensitivity analysis of the three best-quality studies included in the meta-analysis on total testosterone in women with spontaneous POI. women with iatrogenic menopause compared with controls was also statistically significant: WMD (95% CI): 20.29 (20.39 to 20.18) nmol/l. Sensitivity analyses identified that these differences remained robust; heterogeneity decreased significantly in the analysis for spontaneous POI, but remained substantial in the analysis for iatrogenic menopause. It has been hypothesized that women with iatrogenic menopause or spontaneous POI may be at increased risk for hypoandrogenism. Because hypoandrogenism is related to decreased estrogen concentrations (decreased peripheral conversion of testosterone to E 2 by fatty tissue), and possibly to diminished well-being and sexual health (Bachmann et al., 2002) , and increased risk for cardiovascular disease (Laughlin et al., 2010) , it is relevant to evaluate the testosterone concentrations in women with POI or iatrogenic menopause. For spontaneous POI, it is hypothesized that the premature cessation of ovarian function may result in a hypoandrogenic state, which is supported by the findings of the current meta-analysis. However, there is also increasing evidence in the general female population that advancing age per se is associated with decreasing total testosterone concentrations (Labrie et al., 1997; Parker, Jr. et al., 2000; Haring et al., 2011) . The decline in circulating testosterone may occur as a result of atrophy of the ageing adrenal zona reticularis (diminished production of testosterone precursors), which may lead to decreased peripheral conversion of dehydroepiandrosterone sulphate (DHEA-S) (through DHEA) to testosterone (Davison et al., 2005; Panzer and Guay, 2009) . Furthermore, it is debated whether menopause as such is associated with serum testosterone alterations. It has been shown that testosterone levels do not fall abruptly in women undergoing natural menopause due to the preservation of androgen producing theca cells along with elevated LH concentrations (Braunstein, 2002; Fogle et al., 2007) , although the ovarian contribution to circulating testosterone in post-menopausal women remains the topic of extensive debate (Couzinet et al., 2001; Labrie et al., 2011) . Clearly, any ovarian contribution of androgen production is completely stopped in iatrogenic menopause, which is supported by the current findings. The current results for POI may indicate that ovarian production of testosterone is decreased in these women as well, but the underlying mechanisms remain to be clarified.
To control or adjust for the two possible confounders age and BMI (Santoro et al., 2005; Cappola et al., 2007) was an important part of the quality assessment in the current review of total testosterone concentrations in women with spontaneous POI or iatrogenic menopause. Especially in the latter group, these confounders were often not adjusted for, which may have lead to significant between-study heterogeneity. Another explanation for the significant between-study heterogeneity may be the heterogeneous constitution of the control groups in both meta-analyses. While subgroup analyses for type of controls (pre-versus post-menopausal women) also showed high between-study heterogeneity, different age ranges and unclear recruitment procedures for controls may still have been present. Moreover, in the analysis for iatrogenic menopause, heterogeneity in the patient groups existed: BSO was performed for different indications (benign or cancer) and at different ages. A third reason for the encountered between-study heterogeneity may be that none of the studies applied identical testosterone assays. The measurement of testosterone in women is challenging due to lack of trueness, precision and sensitivity of various available testosterone assays (Rosner and Vesper, 2010) , and between-study comparability of results is therefore problematic. Subgroup analyses for direct RIA versus extraction/chromatography RIA or LC-MS/MS identified that heterogeneity between studies became less important when the latter assay types were applied, while a significant difference in the results was identified between the use of these assays in spontaneous POI (x 2 5.23, P ¼ 0.02, I 2 ¼ 80.9%). This is consistent with previously published studies on the performance of testosterone assays (Herold and Fitzgerald, 2003; Stanczyk et al., 2003; Rosner and Vesper, 2010) . Finally, most applied testosterone assays were reported to have high intra-and inter-assay coefficients of variation. The identified differences between cases and controls in this meta-analysis were mostly larger than the analytical variance, and therefore we consider that we may still interpret these results as statistically significant. However, this once again demonstrates that the trueness and precision of testosterone assays need to be improved before testosterone measurements could be used in a clinical setting to distinguish women with hypoandrogenism from normoandrogenic women. Only a limited number of studies have directly investigated the consequences of decreased testosterone concentrations in spontaneous POI and iatrogenic menopause. One study, also included in the current meta-analysis, identified that women with spontaneous POI have diminished general and sexual well-being compared with Figure 5 Sensitivity analysis of the three best-quality studies included in the meta-analysis on total testosterone in women with iatrogenic menopause.
Testosterone in ovarian insufficiency controls. Although significantly lower testosterone concentrations were identified in these women with POI, an independent role for testosterone concentration could not be identified (van der Stege et al., 2008) . However, in agreement with findings in normal menopause, multiple studies have identified that women with iatrogenic menopause are at increased risk for hypoactive sexual desire disorder (Castelo-Branco et al., 2009; Nappi et al., 2009) , diminished healthrelated quality of life (Bhattacharya, 2009) , osteoporosis (Yildiz et al., 1996) and fracture risk (Melton et al., 2003) , parkinsonism (Rocca et al., 2008) or cognitive impairment (Rocca et al., 2007) . These findings are suggestive of a common pathological pathway, but the exact association with decreased testosterone concentrations remains to be determined. Moreover, up until now there is limited evidence for the subscription of androgen therapy in these groups of women. All available studies have investigated androgen therapy in co-treatment with estrogen therapy (Shifren et al., 2000; Buster et al., 2005) , and effects of higher serum testosterone concentrations on the remission of symptoms, such as memory function, are not clear (Moller et al., 2010) .
The current meta-analysis has several limitations. Because only a limited number of studies identified by the literature search met the inclusion criteria, all selected studies were included for review and meta-analysis. This has led to the inclusion of lower-quality studies with small samples sizes, and significant between-study heterogeneity. We have further addressed the issue of low quality androgen assays by additional sensitivity analyses of the best quality studies only (Figs. 3 and 5) . Furthermore, the search was restricted to total testosterone concentrations only. While SHBG, bioavailable testosterone and FT have also been shown to correlate with clinical states such as the metabolic syndrome (Santoro et al., 2005) , it is unclear which of these measurements best reflects the availability of testosterone at tissue level (Matsumoto and Bremner, 2004) .
In conclusion, this literature review and meta-analysis demonstrate that women with spontaneous POI or iatrogenic menopause are at risk for decreased testosterone concentrations. Differentiation between hypoandrogenic and normoandrogenic states within groups of women with premature loss of ovarian function is problematic due to trueness and precision problems in various testosterone assays. The possible effects of hypoandrogenism, and the possible role for androgen therapy in these women remain to be determined.
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